Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826085 · ClinicalTrials.gov registry record · Phase 1
Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall
A Phase 1 study, sponsored by Imunon.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00826085 is a Phase 1 study that has completed, run by Imunon. The registered enrollment target is 17 participants.
The verdict
NCT00826085, a Phase 1 study, has completed, sponsored by Imunon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a research study to evaluate the effects of ThermoDox in combination with therapeutic heating of the chest wall in the treatment of recurrent regional breast cancer. The purpose of this study is to evaluate the bioequivalence of ThermoDox and measure efficacy in recurrent chest wall patients.
Interventions
- DRUG ThermoDox in combination with Microwave Hyperthermia (heat)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826085
The ClinicalTrials.gov registry entry for NCT00826085 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Imunon, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ThermoDox in combination with Microwave Hyperthermia (heat) is the first listed.
NCT00826085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00826085 about?
NCT00826085 is a clinical study titled "Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall". This is a research study to evaluate the effects of ThermoDox in combination with therapeutic heating of the chest wall in the treatment of recurrent regional breast cancer. The purpose of this study is to evaluate the bioequivalence of ThermoDox and measure efficacy in recurrent chest wall patients...
What is the current status of trial NCT00826085?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2013-02. Estimated completion is 2016-06.
What interventions are being tested in trial NCT00826085?
The interventions under investigation include: ThermoDox in combination with Microwave Hyperthermia (heat) (DRUG).
Who is sponsoring clinical trial NCT00826085?
This trial is sponsored by Imunon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.